GSU Event Portal

GSU Event Portal is a web-application offers some events which you have not experienced before. The main motive behind this application is to give the best experience to the visitors. This GSU Event allows users to register for diverse types of events or search for different types of events. It not only allows the users to search or register for the events it helps him to know the different events which are going to take part around his location. To develop this portal, we have used three different roles like Admin, Organizers and Visitors In these three roles Admin and Organizer is used to create the events which the users from the front end can access those using the GSU event portal. This website has user friendly functionalities which he can search for the events from the user portal based on the search criteria he has set. And most important is he can view the event location, details and search for the nearby places using the maps. The Organizer can see only the events which he has created under him this makes event details or user details to be secured. The main aim of this project is to easy and quick access to different events which are created by the Admin and Organizers. As we have some existing applications, but this project helps the users to easy access to the events based on the categories they have selected and provides user to check the registered event

Ex Vivo Antiplatelet and Thrombolytic Activity of Bioactive Fractions from the New-Fangled Stem Buds of <i>Ficus religiosa</i> L. with Simultaneous GC-MS Examination

Different parts of Ficus religiosa are the common components of various traditional formulations for the treatment of several blood disorders. The new-fangled stem buds’ powder was extracted with 80% ethanol and successively fractionated by chloroform and methanol. Chloroform and methanol fractions of Ficus religiosa (CFFR and MFFR) were tested for antiplatelet, antithrombotic, thrombolytic, and antioxidant activity in ex vivo mode. The MFFR was particularly investigated for GC-MS and toxicity. The antiplatelet activity of the CFFR, MFFR, and standard drug aspirin at 50 μg/mL was 54.32%, 86.61%, and 87.57%, and a significant delay in clot formation was noted. CFFR at different concentrations did not show a significant effect on the delay of clot formation, antiplatelet, and free radical scavenging activity. The most possible marker compounds for antiplatelet and antioxidant activity identified by GC-MS in the MFFR are salicylate derivatives aromatic compounds such as benzeneacetaldehyde (7), phenylmalonic acid (13), and Salicylic acid (14), as well as Benzamides derivatives such as carbobenzyloxy-dl-norvaline (17), 3-acetoxy-2(1H)-pyridone (16), and 3-benzylhexahydropyrrolo [1,2-a] pyrazine-1,4-dione (35). A toxicity study of MFFR did not show any physical indications of toxicity and mortality up to 1500 mg/kg body weight and nontoxic up to 1000 mg/kg, which is promising for the treatment of atherothrombotic diseases